mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.17 |
0.003 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.004 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |